Qubiotech Health Intelligence,
Computer aided detection tools to get quantification on medical images.
- biotechnology
- horizon europe
- dt and ls
- biotech and pharma
- analytics
- eit ecosystem
- neurology
- eit health
- seal of excellence ec
- digital pharma
- medical diagnostics
- medical imaging
- investor network (eit health)
- bridgehead europe (eit health)
- investor network 2018 (eit health)
- product market fit (eit health)
- bridgehead europe 2019 (eit health)
- product market fit 2017 (eit health)
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 400 % | (44 %) | (13 %) | 49 % | 165 % | 10 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 1 % | 45 % | (407 %) | (132 %) | (38 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (4 %) | 23 % | (326 %) | (112 %) | (32 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Qubiotech Health Intelligence is a forward-thinking company specializing in the development and commercialization of advanced software for processing and quantifying medical images. Founded in December 2014, Qubiotech emerged from the innovative work of the Nuclear Medicine and Molecular Imaging Research Group at the Health Research Institute Foundation. The company focuses on creating software solutions that assist healthcare professionals in diagnosing and monitoring neurological conditions through detailed image analysis.
Qubiotech primarily serves medical institutions, research centers, and healthcare professionals who require precise imaging tools for conditions such as multiple sclerosis, epilepsy, and other neurological disorders. The company operates within the healthcare technology market, specifically targeting the niche of medical imaging software.
The business model of Qubiotech revolves around the development and licensing of its proprietary software. Their flagship products include Neurocloud VOL and Neurocloud SPECT, which provide comprehensive analysis and reporting tools for medical images. These tools help in identifying and quantifying lesions, monitoring disease progression, and comparing patient data against a database of healthy controls. By offering these advanced solutions, Qubiotech enables healthcare providers to make more informed decisions, ultimately improving patient outcomes.
Qubiotech generates revenue through the sale of software licenses and subscriptions. Medical institutions and professionals pay for access to Qubiotech's software, which they use to enhance their diagnostic capabilities. Additionally, the company may engage in research and development collaborations, further expanding its revenue streams and fostering innovation.
In summary, Qubiotech Health Intelligence is a key player in the medical imaging software industry, providing essential tools for the accurate diagnosis and monitoring of neurological diseases. Its advanced software solutions support healthcare professionals in delivering better patient care.
Keywords: medical imaging, software, healthcare, diagnostics, neurological disorders, multiple sclerosis, epilepsy, Neurocloud, image analysis, healthcare technology.